Advances in Fungal Peptide Vaccines

• Main Authors: Leandro B. R. Da Silva, Carlos P. Taborda, Joshua D. Nosanchuk
• Format: Article
• Language: English
• Published: MDPI AG 2020-07-01
• Series: Journal of Fungi
• Subjects: fungal; vaccine; peptides; <i>paracoccidioides</i>; <i>sporothrix</i>; <i>aspergillus</i>
• Online Access: https://www.mdpi.com/2309-608X/6/3/119

Vaccination is one of the greatest public health achievements in the past century, protecting and improving the quality of life of the population worldwide. However, a safe and effective vaccine for therapeutic or prophylactic treatment of fungal infections is not yet available. The lack of a vaccine for fungi is a problem of increasing importance as the incidence of diverse species, including <i>Paracoccidioides, Aspergillus, Candida, Sporothrix</i>, and <i>Coccidioides</i>, has increased in recent decades and new drug-resistant pathogenic fungi are emerging. In fact, our antifungal armamentarium too frequently fails to effectively control or cure mycoses, leading to high rates of mortality and morbidity. With this in mind, many groups are working towards identifying effective and safe vaccines for fungal pathogens, with a particular focus of generating vaccines that will work in individuals with compromised immunity who bear the major burden of infections from these microbes. In this review, we detail advances in the development of vaccines for pathogenic fungi, and highlight new methodologies using immunoproteomic techniques and bioinformatic tools that have led to new vaccine formulations, like peptide-based vaccines.